Vaccine strategies to induce tumor-specific immunity in the absence of known tumor associated antigens
Lewis, J.D.; Patterson, E.K.; Shearer, M.H.; Kennedy, R.C.; Bright, R.K.
Proceedings of the American Association for Cancer Research 44: 169
2003
ISSN/ISBN: 0569-2261 Accession: 036024726
PDF emailed within 1 workday: $29.90
Related References
Wu, Y.; Wan, Y.; Bian, J.; Zhao, J.; Jia, Z.; Zhou, L.; Zhou, W.; Tan, Y. 2002: Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine P815 model International Journal of Cancer 98(5): 748-753Esquerré, M.ël.; Momot, M.; Goubier, A.; Gonindard, C.; Leung-Theung-Long, S.ép.; Misseri, Y.; Bissery, M.-C. 2017: GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth Vaccine 35(11): 1509-1516
Sano, S.; Izumi, Y.; Sugihara, S.; Nakajima, H.; Fujiwara, H.; Hamaoka, T. 1987: The generation of tumor-specific in vivo protective immunity in the tumor mass from mice rendered tolerant to tumor antigens Cancer Immunology Immunotherapy: Cii 25(2): 105-110
Marcu, A.; Eyrich, M. 2019: Therapeutic vaccine strategies to induce tumor-specific T-cell responses Bone Marrow Transplantation 54(Suppl. 2): 806-809
Mathiassen, S.; Lauemøller, S.L.; Ruhwald, M.; Claesson, M.H.; Buus, S. 2001: Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity European Journal of Immunology 31(4): 1239-1246
Shibagaki, N.; Udey, M. 2001: Dendritic cells treated with TAT protein transduction domain -containing recombinant tumor antigens efficiently induce cytotoxic lymphocytes and tumor immunity Journal of Investigative Dermatology 117(2): 449
Li, X.; Bukawa, H.; Hirota, M.; Tsuyuki, Y.; Omura, S.; Fujita, K. 2003: Novel OK-432-conjugated tumor vaccines induce tumor-specific immunity against murine tongue cancer Journal of Dental Research 82(8): 636-640
Baskar, S.; Azarenko, V.; Garcia Marshall, E.; Hughes, E.; Ostrand-Rosenberg, S. 1994: MHC class II-transfected tumor cells induce long-term tumor-specific immunity in autologous mice Cellular Immunology 155(1): 123-133
Rescigno, M.; Valzasina, B.; Bonasio, R.; Urbano, M.; Ricciardicastagnoli, P. 2001: Dendritic cells, loaded with recombinant bacteria expressing tumor antigens, induce a protective tumor-specific responses Clin. Cancer Res 7(3): 865s-870s
Rescigno, M.; Valzasina, B.; Bonasio, R.; Urbano, M.; Ricciardi-Castagnoli, P. 2001: Dendritic cells, loaded with recombinant bacteria expressing tumor antigens, induce a protective tumor-specific response Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(3 Suppl): 865s-870s
Brannen, G.E.; Adams, J.S.; Santos, G.W. 1974: In vivo demonstration of tumor specific immunity with soluble tumor antigens in the mouse Proceedings of the American Association for Cancer Research 15: 76
Bergers, J.J.; Den Otter, W.; Dullens, H.F.; De Groot, J.W.; Steerenberg, P.A.; Filius, P.M.; Crommelin, D.J. 1994: Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigens International Journal of Cancer 56(5): 721-726
Chism, S.E.; Burton, R.C.; Warner, N.L. 1977: In vitro induction of tumor specific immunity assessment of specificity of response to tumor antigens Proceedings of the American Association for Cancer Research 18: 26
Schroit, A.J.; Key, M.E. 1983: Induction of syngeneic tumour-specific immunity by liposomes reconstituted with L2C tumour-cell antigens Immunology 49(3): 431-438
Fu, Z.-X.; Han, J.-S.; Liu, F.; Zhao, Z.-L.; Li, D.-B.; Shi, L.; Dong, J.-T.; Zhou, Y.; Cai, J.-H. 2017: The study on specific umbilical blood Dc vaccine for Beige nude mice loaded human colorectal carcinoma to induce anti-tumor immunity European Review for Medical and Pharmacological Sciences 21(10): 2364-2371
Pellis, N.R.; Shulan, D.J.; Kahan, B.D. 1976: Specific tumor immunity induced with soluble materials: purification of antigens inducing tumor resistance Biochemical and Biophysical Research Communications 71(4): 1251-1258
Meltzer, M.S.; Oppenheim, J.J.; Littman, B.H.; Leonard, E.J.; Rapp, H.J. 1972: Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens Journal of the National Cancer Institute 49(3): 727-734
Yoshioka, T.; Fukuzawa, M.; Takai, Y.; Wakamiya, N.; Ueda, S.; Kato, S.; Fujiwara, H.; Hamaoka, T. 1986: The augmentation of tumor-specific immunity by virus help. III. Enhanced generation of tumor-specific Lyt-1+2- T cells is responsible for augmented tumor immunity in vivo Cancer Immunology Immunotherapy: Cii 21(3): 193-198
Yoshioka, T.; Fukuzawa, M.; Takai, Y.; Wakamiya, N.; Ueda, S.; Kato, S.; Fujiwara, H.; Hamaoka, T. 1986: The augmentation of tumor-specific immunity by virus help. III: enhanced generation of tumor-specific Lyt-1+2-T cells is reponsible for augmented tumor immunity in vivo Cancer Immunology and ImmunoTherapy 21(3): 193-198
Hui, K.M.; Kim, B.S. 1984: Tumor-specific immunity induced by somatic hybrids. IV. Relationship between immunogenicity and expression of surface tumor-associated antigens Cellular Immunology 87(2): 591-600